Impact of Post-Transplant High-Dose Cyclophosphamide on Reconstitution in Bone Marrow Recipients

被引：0
|
作者：
Mikhaltsova, Ekaterina
Drokov, Mikhail Yu.
Davydova, Julia O.
Kuzmina, Larisa A.
Popova, Natalia
Dubnyak, Daria
Vasilyeva, Vera
Koroleva, Olga
Konova, Zoya
Kapranov, Nikolay M.
Galtseva, Irina V.
Parovichnikova, Elena N.
Savchenko, Valery
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5485
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Haploidentical non-myeloablative bone marrow transplant with post-infusion high-dose cyclophosphamide as GvHD prophylaxis in high-risk patients
    Gayoso, J.
    Balsalobre, P.
    Serrano, D.
    Rodriguez-Macias, G.
    Kwon, M.
    Munoz, C.
    Anguita, J.
    Perez-Corral, A.
    Gomez-Pineda, A.
    Buno, I.
    Diez-Martin, J. L.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S400 - S400
  • [42] Impact of Graft Cell Dose on Outcomes after Matched Sibling Donor Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis
    Shahzad, Moazzam
    Kasaeian, Amir
    Amin, Muhammad Kashif
    Khalid, Muhammad Fareed
    Khavandgar, Naghmeh
    Alemi, Hediyeh
    Chaudhary, Sibgha Gull
    Anwar, Igra
    Mcguirk, Matthew
    Abhyankar, Sunil
    Hamadani, Mehdi
    Mcguirk, Joseph P.
    Mushtag, Muhammad Umair
    BLOOD, 2024, 144 : 7277 - 7278
  • [43] High-dose cyclophosphamide (Cy) without bone marrow transplant in the treatment of children with severe aplastic anemia (SAA).
    González-Llano, O
    Jaime-Pérez, JC
    Herrera-Garza, JL
    Gómez-Almaguer, D
    BLOOD, 1998, 92 (10) : 16B - 16B
  • [44] TREATMENT OF REFRACTORY SOLID TUMORS WITH HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANT
    GRAHAM, ML
    YEAGER, AM
    BRAINE, HG
    SARAL, R
    SANTOS, GW
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 616 - 616
  • [45] High-dose cyclophosphamide (CY) without bone marrow transplant (BMT) for refractory severe autoimmune diseases (SADS).
    Petri, M
    Jones, RJ
    Smith, BD
    Brodsky, I
    Anhalt, G
    Brodsky, RA
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S242 - S242
  • [46] Checkpoint Inhibitor Therapy and Graft Versus Host Disease in Allogeneic Bone Marrow Transplant Recipients of Haploidentical and Matched Products with Post-Transplant Cyclophosphamide.
    Schoch, Laura K.
    Borrello, Ivan
    Fuchs, Ephraim J.
    Bolanos-Meade, Javier
    Huo, Jeffrey Sean
    Gojo, Ivana
    Wagner-Johnston, Nina
    Prince, Gabrielle T.
    McCurdy, Shannon R.
    Smith, B. Douglas
    DeZern, Amy E.
    Showel, Margaret M.
    Loeb, David
    Shad, Aziza T.
    Jones, Richard J.
    Ambinder, Richard F.
    Gladstone, Douglas
    BLOOD, 2016, 128 (22)
  • [47] High-dose cyclophosphamide (Cy) without bone marrow transplant (BMT) for refractory severe autoimmune diseases (SADS).
    Brodsky, RA
    Smith, BD
    Brodsky, I
    Anhalt, G
    Petri, M
    Jones, RJ
    BLOOD, 1997, 90 (10) : 1028 - 1028
  • [48] Myeloablative haploidentical bone marrow transplantation with post-transplant cyclophosphamide in paediatric patients with haematological malignancies
    Sen, Santanu
    Tulpule, Sameer
    BONE MARROW TRANSPLANTATION, 2019, 54 : 226 - 227
  • [49] Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML
    A Rashidi
    M Slade
    J F DiPersio
    P Westervelt
    R Vij
    R Romee
    Bone Marrow Transplantation, 2016, 51 : 1561 - 1564
  • [50] Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant
    Raiola, Anna Maria
    Ghiso, Anna
    Dominietto, Alida
    Di Grazia, Carmen
    Gualandi, Francesca
    Varaldo, Riccardo
    Galaverna, Federica
    Van Lint, Maria Teresa
    Lamparelli, Teresa
    Bregante, Stefania
    Miglino, Maurizio
    Ballerini, Filippo
    Bacigalupo, Andrea
    BLOOD, 2013, 122 (21)
12345